Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annual Review of Pharmacology and Toxicology|September 16, 2024
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a DishZehra Yildirim, Kyle Swanson, Xuekun Wu, et al.
Cardiovascular Research|October 16, 2020
Angiogenesis after acute myocardial infarctionXuekun Wu, Marc R Reboll, Mortimer Korf-Klingebiel, et al.
Trends in Pharmacological Sciences|August 28, 2025
Cardiac fibrosis: from mechanisms and models to medicinesWenqiang Liu, Xuekun Wu, Wenshu Zeng, et al.
Science (New York, N.Y.)|April 16, 2026
Reimagining human-centric drug development with new approach methodologiesXuekun Wu, Matthew A Wu, James Zou, et al.
European Heart Journal|September 13, 2024
Clinical trials in-a-dish for cardiovascular medicineXuekun Wu, Kyle Swanson, Zehra Yildirim, et al.
Frontiers in Pediatrics|September 6, 2021
Developing and Testing the Validity and Reliability of the Brief Adolescent Respiratory System Health Assessment Scale-Student Version in a Chinese SampleLingwei Tao, Yana Gao, Hongzhe Dou, et al.
Circulation. Cardiovascular Quality and Outcomes|June 1, 2018
Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in ChinaErica S Spatz, Yongfei Wang, Adam L Beckman, et al.
Circulation Research|August 23, 2019
Heparan Sulfate-Editing Extracellular Sulfatases Enhance VEGF Bioavailability for Ischemic Heart RepairMortimer Korf-Klingebiel, Marc R Reboll, Karsten Grote, et al.
Nature Cardiovascular Research|August 28, 2024
Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repairXuekun Wu, Linqun Zheng, Marc R Reboll, et al.
Cell|October 16, 2024
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic targetHao Zhang, Phung N Thai, Rabindra V Shivnaraine, et al.
Pageof 2